Clinical Trial Update: Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases [NA]

View source ↗

Summary

Trial update for Ferumoxytol assessing its utility in improving MR imaging for high-grade brain tumors and cerebral metastases; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Malignant Glioma
• Malignant Neoplasm in the Brain

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Central Nervous System Lymphoma, Malignant Glioma | NA | Status: COMPLETED | Results posted: 2022-06-09